These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 26401197)
1. [Frequency, clinical implication and prognostic value of lymphopenia in systemic lupus erythematosus: case-control study]. Ha-ou-nou FZ; Essaadouni L Pan Afr Med J; 2015; 21():3. PubMed ID: 26401197 [TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Massardo L; Metz C; Pardo E; Mezzano V; Babul M; Jarpa E; Guzmán AM; André S; Kaltner H; Gabius HJ; Jacobelli S; González A; Soza A Lupus; 2009 May; 18(6):539-46. PubMed ID: 19395456 [TBL] [Abstract][Full Text] [Related]
3. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779 [TBL] [Abstract][Full Text] [Related]
4. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients. Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480 [TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD; Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840 [TBL] [Abstract][Full Text] [Related]
6. Lymphocytopenia in lupus erythematosus: close in vivo association to autoantibodies targeting nuclear antigens. Wenzel J; Gerdsen R; Uerlich M; Bauer R; Tueting T; Bieber T Br J Dermatol; 2004 May; 150(5):994-8. PubMed ID: 15149515 [TBL] [Abstract][Full Text] [Related]
7. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Rivero SJ; Díaz-Jouanen E; Alarcón-Segovia D Arthritis Rheum; 1978 Apr; 21(3):295-305. PubMed ID: 646828 [TBL] [Abstract][Full Text] [Related]
8. [Various immunological indicators in patients with allergic dermatitis and systemic lupus erythematosus under the climatic conditions of Uzbekistan]. Abidov MM; Burshteĭn ChI; Kazakova VI Vestn Dermatol Venerol; 1982 Feb; (2):33-7. PubMed ID: 6461144 [No Abstract] [Full Text] [Related]
9. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Jarpa E; Babul M; Calderón J; González M; Martínez ME; Bravo-Zehnder M; Henríquez C; Jacobelli S; González A; Massardo L Lupus; 2011 Jan; 20(1):58-66. PubMed ID: 21078764 [TBL] [Abstract][Full Text] [Related]
10. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. Ng WL; Chu CM; Wu AK; Cheng VC; Yuen KY QJM; 2006 Jan; 99(1):37-47. PubMed ID: 16371405 [TBL] [Abstract][Full Text] [Related]
11. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus. Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107 [TBL] [Abstract][Full Text] [Related]
12. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus. Cohen MR; Crosby D J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346 [TBL] [Abstract][Full Text] [Related]
13. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860 [TBL] [Abstract][Full Text] [Related]
14. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity. Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 related to lymphopenia in lupus. Dima A; Pricopi I; Balanescu E; Balanescu P; Baicus C Eur J Intern Med; 2019 Jun; 64():e9-e10. PubMed ID: 31036439 [No Abstract] [Full Text] [Related]
16. Apoptosis: the link between autoantibodies and leuko-/lymphocytopenia in patients with lupus erythematosus. Böhm I Scand J Rheumatol; 2004; 33(6):409-16. PubMed ID: 15794201 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471 [TBL] [Abstract][Full Text] [Related]
18. [Systemic lupus erythematosus and lymphopenia: Clinical and pathophysiological features]. Martin M; Guffroy A; Argemi X; Martin T Rev Med Interne; 2017 Sep; 38(9):603-613. PubMed ID: 28214184 [TBL] [Abstract][Full Text] [Related]